Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/12/09 |
Seattle
|
|
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money
|
Luke Timmerman |
11/11/09 |
Seattle
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Seattle Genetics Adds Marketing Boss
|
Luke Timmerman |
10/13/09 |
Seattle
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Ambrx Strikes Deal With Wyeth (Soon-to-be Pfizer) to Make Antibody Drugs
|
Luke Timmerman |
09/18/09 |
San Diego
|
|
Ambit Biosciences, In Third Incarnation, Gears Up for Pivotal Study of Leukemia Drug
|
Luke Timmerman |
09/10/09 |
San Diego
|
|
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Seattle Genetics Gets Milestone
|
Luke Timmerman |
09/08/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies
|
Luke Timmerman |
08/25/09 |
Seattle
|
|
Seattle Genetics Trial Fills Up
|
Luke Timmerman |
08/24/09 |
Seattle
|
|
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
iLike Courts MySpace, Microsoft and Nokia Tie the Knot, Madrona Funds Three Startups, & More Seattle-Area Deals News
|
Gregory T. Huang |
08/19/09 |
Seattle
|
|
Seattle Genetics Gets $136M Total
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed
|
Luke Timmerman |
08/12/09 |
Seattle
|
|
Seattle Genetics Raising $118M
|
Eric Hal Schwartz |
08/11/09 |
Seattle
|
|
Seattle Genetics Snags Milestone
|
Luke Timmerman |
08/10/09 |
Seattle
|
|
Seattle Genetics Starts New Trial
|
Luke Timmerman |
06/18/09 |
Seattle
|
|
NanoString Nabs $30M in Third Venture Round (Which It Hopes Will Be The Last)
|
Luke Timmerman |
06/09/09 |
Seattle
|
|
Alder Expands Partnership with Schering-Plough, Adds “Significant” Upfront Cash
|
Luke Timmerman |
06/08/09 |
Seattle
|
|
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/04/09 |
Seattle
|
|
Facebook Funds Seattle Startups, 1000 Markets Gets Seed Financing, Modumetal Closes Equity Round, & More Seattle-Area Deals News
|
Gregory T. Huang |
06/02/09 |
Seattle
|
|
Seattle Genetics Pockets $11.5M
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
Seattle Genetics “Empowered Antibody” Wipes Out Hodgkin’s Tumors in Early Study
|
Luke Timmerman |
06/01/09 |
Seattle
|
|
Vulcan’s Biotech Windfall, BiPar Sciences, Sparks “Fundamental” Cancer Advance
|
Luke Timmerman |
05/22/09 |
Seattle
|
|
ASCO Preview: Seattle Genetics, ZymoGenetics, Trubion & Other Seattle Biotechs Offer Peeks at Cancer Drug Results
|
Luke Timmerman |
05/15/09 |
Seattle
|
|
Why Should the Public Care About Biotech? Why is the Answer Always Jobs?
|
Luke Timmerman |
04/24/09 |
Seattle
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
